Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Operating Expenses | 54,563 | 0 | 0 |
| Operating Income | -54,563 | N/A | N/A |
| Other Income | -656 | 0 | 0 |
| Pre-tax Income | -55,219 | 0 | 0 |
| Net Income Continuous | -55,219 | N/A | N/A |
| Net Income | $-55,219 | $N/A | $N/A |
| EPS Basic Total Ops | -1,476.47 | N/A | N/A |
| EPS Basic Continuous Ops | -1,476.51 | N/A | N/A |
| EPS Diluted Total Ops | -1,476.47 | N/A | N/A |
| EPS Diluted Continuous Ops | -1,476.51 | N/A | N/A |
| EBITDA(a) | $-53,498 | $N/A | $N/A |